These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
539 related articles for article (PubMed ID: 32993166)
41. Acceleration of chondrogenic differentiation of human mesenchymal stem cells by sustained growth factor release in 3D graphene oxide incorporated hydrogels. Shen H; Lin H; Sun AX; Song S; Wang B; Yang Y; Dai J; Tuan RS Acta Biomater; 2020 Mar; 105():44-55. PubMed ID: 32035282 [TBL] [Abstract][Full Text] [Related]
42. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells. Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865 [TBL] [Abstract][Full Text] [Related]
43. Influence of alginate backbone on efficacy of thermo-responsive alginate-g-P(NIPAAm) hydrogel as a vehicle for sustained and controlled gene delivery. Chalanqui MJ; Pentlavalli S; McCrudden C; Chambers P; Ziminska M; Dunne N; McCarthy HO Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():409-421. PubMed ID: 30573265 [TBL] [Abstract][Full Text] [Related]
44. Paclitaxel Loaded Nanoliposomes in Thermosensitive Hydrogel: A Dual Approach for Sustained and Localized Delivery. Mahajan M; Utreja P; Jain SK Anticancer Agents Med Chem; 2016; 16(3):365-76. PubMed ID: 26255673 [TBL] [Abstract][Full Text] [Related]
45. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. Bhattarai N; Ramay HR; Gunn J; Matsen FA; Zhang M J Control Release; 2005 Apr; 103(3):609-24. PubMed ID: 15820408 [TBL] [Abstract][Full Text] [Related]
46. In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer. Lo YW; Sheu MT; Chiang WH; Chiu YL; Tu CM; Wang WY; Wu MH; Wang YC; Lu M; Ho HO Acta Biomater; 2019 Mar; 86():280-290. PubMed ID: 30616077 [TBL] [Abstract][Full Text] [Related]
47. pH-responsive injectable hydrogels with mucosal adhesiveness based on chitosan-grafted-dihydrocaffeic acid and oxidized pullulan for localized drug delivery. Liang Y; Zhao X; Ma PX; Guo B; Du Y; Han X J Colloid Interface Sci; 2019 Feb; 536():224-234. PubMed ID: 30368094 [TBL] [Abstract][Full Text] [Related]
48. Injectable and self-healing nanocomposite hydrogel loading needle-like nano-hydroxyapatite and graphene oxide for synergistic tumour proliferation inhibition and photothermal therapy. Qi Y; Qian Z; Yuan W; Li Z J Mater Chem B; 2021 Dec; 9(47):9734-9743. PubMed ID: 34787633 [TBL] [Abstract][Full Text] [Related]
49. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121 [TBL] [Abstract][Full Text] [Related]
50. Osteogenic differentiation and ectopic bone formation of canine bone marrow-derived mesenchymal stem cells in injectable thermo-responsive polymer hydrogel. Liao HT; Chen CT; Chen JP Tissue Eng Part C Methods; 2011 Nov; 17(11):1139-49. PubMed ID: 21870942 [TBL] [Abstract][Full Text] [Related]
51. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Bao H; Pan Y; Ping Y; Sahoo NG; Wu T; Li L; Li J; Gan LH Small; 2011 Jun; 7(11):1569-78. PubMed ID: 21538871 [TBL] [Abstract][Full Text] [Related]
52. Targeted and controlled drug delivery by multifunctional mesoporous silica nanoparticles with internal fluorescent conjugates and external polydopamine and graphene oxide layers. Tran AV; Shim K; Vo Thi TT; Kook JK; An SSA; Lee SW Acta Biomater; 2018 Jul; 74():397-413. PubMed ID: 29775731 [TBL] [Abstract][Full Text] [Related]
53. Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects. Seraj S; Cho YJ; Lee JW; Ahn HJ Biochem Pharmacol; 2020 Jan; 171():113735. PubMed ID: 31786264 [TBL] [Abstract][Full Text] [Related]
54. EGFR-targeted hybrid lipid nanoparticles for chemo-photothermal therapy against colorectal cancer cells. Fang F; Zhang X; Tang J; Wang Y; Xu J; Sun Y Chem Phys Lipids; 2023 Mar; 251():105280. PubMed ID: 36634728 [TBL] [Abstract][Full Text] [Related]
55. Bioinspired pH- and Temperature-Responsive Injectable Adhesive Hydrogels with Polyplexes Promotes Skin Wound Healing. Le TMD; Duong HTT; Thambi T; Giang Phan VH; Jeong JH; Lee DS Biomacromolecules; 2018 Aug; 19(8):3536-3548. PubMed ID: 30005160 [TBL] [Abstract][Full Text] [Related]
56. A chitosan-graft-PEI-candesartan conjugate for targeted co-delivery of drug and gene in anti-angiogenesis cancer therapy. Bao X; Wang W; Wang C; Wang Y; Zhou J; Ding Y; Wang X; Jin Y Biomaterials; 2014 Sep; 35(29):8450-66. PubMed ID: 24997481 [TBL] [Abstract][Full Text] [Related]
57. Low-molecular weight chitosan/vascular endothelial growth factor short hairpin RNA for the treatment of hepatocellular carcinoma. Huang Z; Dong L; Chen J; Gao F; Zhang Z; Chen J; Zhang J Life Sci; 2012 Dec; 91(23-24):1207-15. PubMed ID: 23044224 [TBL] [Abstract][Full Text] [Related]
58. Injectable hydrogel for sustained delivery of progranulin derivative Atsttrin in treating diabetic fracture healing. Moradi L; Witek L; Vivekanand Nayak V; Cabrera Pereira A; Kim E; Good J; Liu CJ Biomaterials; 2023 Oct; 301():122289. PubMed ID: 37639975 [TBL] [Abstract][Full Text] [Related]
59. Graphene Oxide-Carbamoylated Chitosan Hydrogels with Tunable Mechanical Properties for Biological Applications. Gupta R; Swarupa S; Mayya C; Bhatia D; Thareja P ACS Appl Bio Mater; 2023 Feb; 6(2):578-590. PubMed ID: 36655342 [TBL] [Abstract][Full Text] [Related]
60. Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid)) for doxorubicin delivery in breast cancer. Fathi M; Alami-Milani M; Geranmayeh MH; Barar J; Erfan-Niya H; Omidi Y Int J Biol Macromol; 2019 May; 128():957-964. PubMed ID: 30685304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]